LGALS3 and breast carcinoma: In summary, this study followed breast cancer patients who presented prior to any anticancer treatment in an attempt to clearly examine how surgery, chemotherapy, and the disease itself alters secreted levels of Gal-3 in plasma and tumor stroma.